Previous studies show that combining Bcl‐2 family inhibitors such as ABT‐737 with gemcitabine enhances apoptosis in pancreatic cancer cells, overcoming drug resistance mechanisms.33 The gene discussed is BCL2; the disease is familial pancreatic carcinoma.